News
Latest News and Press Releases
A paper describing the drug discovery research of the CDK12 inhibitor CTX-439 has been published in ACS Medicinal Chemistry Letters
Discovery of CTX-439: A Potent and Selective CDK12 Inhibitor as a Prospective Anti-Cancer Drug Publication Published Date:...
Axcelead DDP Joins Lilly TuneLab to Advance AI Drug Discovery
Fujisawa, Japan, June 18, 2026 — Axcelead Drug Discovery Partners, Inc. (Axcelead DDP) is pleased to announce...
Co-authored Paper by Researcher Matsumoto and Researcher Miura of the Translational Research Business Unit Published in Gut Pathogens
Cross-organ multi-omics profiling of microbiome and metabolome along the gut-liver axis in MASH model mice induced by...
Proteros and Axcelead DDP Enter Strategic Collaboration to Enhance Discovery Capabilities
Proteros and Axcelead DDP Enter Strategic Collaboration to Enhance Discovery Capabilities Axcelead gains access to Proteros’ capabilities...
A co-authored paper by researcher Miura of the DMPK & Safety Business Unit was published in Metabolites
Investigation of storage conditions and quality control markers for metabolites and lipids in human feces Publication Published...
